Vesilute or Vesilut appears to be one of Khavinson’s peptides, which are considered bioregulators that may interact with specific parts of DNA and support gene expression. It has the sequence of Glu-Asp (Glutamic Acid – Aspartic Acid), or ED for short.

This sequence is believed to interact and possibly exert an epigenetic action on the DNA sequences of ATTT. Below, we have broken down the available research on Vesilute, as well as on similar peptides, due to the scarcity of research focusing specifically on this peptide.

 

Research

Vesilute Potential DNA Interactions

Vesilute may have the ability to interact with parts of the DNA and particularly ATTT sequences. The overall strength of the binding may be relatively weak, which is thought by researchers to be a characteristic shared among dipeptides due to their limited area of contact. Research conducted by Khavinson et al. suggests Vesilute might be capable of permeating both cytoplasmic and nuclear membranes due to specific physicochemical properties such as charge, size, and hydrophobicity.(1)

According to research mike this, once inside the nuclear environment, Vesilute may interact directly with complementary sequences in gene promoters. It is theorized that this epigenetic interaction might potentially stimulate the synthesis of relevant mRNA, thereby possibly triggering downstream translation processes.

This posited mechanism might theoretically regulate fundamental cellular activities in in vitro models, such as “gene expression and protein synthesis, [may] stimulate cell proliferation and differentiation, and [mitigate] apoptosis”.

Furthermore, these researchers and others note that similar short peptides display the potential to alter cellular physiological resources. Yet, research on Vesilute is scarce, and the specific investigations into it primarily highlight its basic capacity to epigenetically support mammalian genetic activity.

Vesilute and Vesilute-like Peptides

Further research by Khavinson et al. suggests that peptides like Vesilute may have potential in “short peptides activate heterochromatin and heterochromatinized regions of cell chromosomes [in aged]” cellular models.(2) It is posited that this synthetic short peptide may induce the activation of ribosomal genes by promoting the decondensation of densely packed chromatin fibrils. Consequently, this process potentially facilitates the release of genes that may have been previously repressed due to cellular age-associated heterochromatinization.

Specifically, the relevance of Vesilute-like peptides in cellular assays seemingly leads to the decondensation of pericentromeric structural chromatin in chromosome 1, while possibly inducing structural alterations in chromosome 9 as well.

Such changes suggest a potential selective capacity to decrease the size of specific structural heterochromatin blocks. Furthermore, thermal stability analyses indicate that peptides like Vesilute potentially shift chromatin denaturation endotherms toward lower temperatures.

This phenomenon is posited to reflect the unfolding of higher-level chromatin organizations, maybe through the partial despiralization of fixed loops down to the level of 30-nm fibrils. The peptide apparently increases the incidence of sister chromatid exchanges, particularly affecting chromosome groups A, C, D, and G. This elevated exchange rate may signify a decondensation of heterochromatinized euchromatin regions, allowing for renewed genetic activity.

NOTE: These products are intended for laboratory research use only. This peptide is not intended for personal use. Please review and adhere to our Terms and Conditions before ordering.

 

References:

  1. Khavinson, V. K., Lin’kova, N. S., & Tarnovskaya, S. I. (2016). Short peptides regulate gene expression. Bulletin of experimental biology and medicine, 162(2), 288-292.
  2. Khavinson VKh, Lezhava TA, Malinin VV. Effects of short peptides on lymphocyte chromatin in senile subjects. Bull Exp Biol Med. 2004 Jan;137(1):78-81. PMID: 15085253. https://doi.org/10.1023/b:bebm.0000024393.40560.05

Dr. Marinov

Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research.

0
    Your Cart
    Your cart is empty